Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Icon ( (ICLR) ) is now available.
On June 18, 2025, ICON plc released its unaudited interim financial statements for the period from January 1 to June 5, 2025. The company reported a profit of $477,999,000, showing an increase from the previous year’s profit of $425,295,000. The total comprehensive income for the period was $478,997,000, reflecting a positive currency translation difference. This financial performance underscores ICON’s strong operational capabilities and its strategic positioning in the clinical research industry, potentially benefiting stakeholders by reinforcing the company’s market strength and financial stability.
The most recent analyst rating on (ICLR) stock is a Buy with a $380.00 price target. To see the full list of analyst forecasts on Icon stock, see the ICLR Stock Forecast page.
Spark’s Take on ICLR Stock
According to Spark, TipRanks’ AI Analyst, ICLR is a Neutral.
Icon’s overall score reflects a mix of strong financial performance and efficient cash flow management, weighed down by technical indicators showing a bearish trend and a cautious outlook from the earnings call. The valuation is moderate, but the lack of dividend yield limits appeal for certain investors. The company’s focus on innovation and partnerships provides a potential for mid-to-long-term growth, but current market challenges and revenue declines pose significant risks.
To see Spark’s full report on ICLR stock, click here.
More about Icon
ICON plc operates within the clinical research industry, providing outsourced development services to the pharmaceutical, biotechnology, and medical device sectors. The company focuses on offering comprehensive solutions for clinical trials, including data management, regulatory support, and laboratory services, positioning itself as a key player in the global healthcare market.
Average Trading Volume: 1,499,554
Technical Sentiment Signal: Sell
Current Market Cap: $11.87B
For detailed information about ICLR stock, go to TipRanks’ Stock Analysis page.